NK Stock Price Increases Over 15% Pre-Market: Why It Happened
NK Stock Price Increases Over 12% Pre-Market: Why It Happened
NantKwest/ImmunityBio's COVID-19 Vaccine Candidate To Be Tested For Oral And Sublingual Route Of Administration
NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars
NantKwest Stock Price Increases 9.93%: Why It Happened
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
North Star Investment Management Corp. Makes New $61,000 Investment in Nantkwest Inc (NASDAQ:NK)
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Hospital led by biotech billionaire Soon-Shiong approved for PPP aid
Nantkwest (NASDAQ:NK) Shares Gap Up to $11.80
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
Nantkwest (NASDAQ:NK) Stock Price Up 7.9%
NantKwest : Announces Pricing of Public Offering of Common Stock | MarketScreener
NANTKWEST, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener
NantKwest : Announces Proposed Public Offering of Common Stock | MarketScreener
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
Nantkwest (NASDAQ:NK) Upgraded at BidaskClub